R3 GLP
Description
A novel synthetic peptide and triple hormone receptor agonist (GIP, GLP-1, and glucagon receptors) researched for its potent multi-pathway modulation of metabolic rate, glucose homeostasis, and lipid regulation.
Available in 5mg–60mg vials, every lot is third-party tested for identity and purity, with certificates of analysis available on request. Vials arrive sealed and sterile, lyophilized for stability, and ship from our U.S. facility in 2–6 days.
For in vitro laboratory research use only. See the Technical Data tab below for the full mechanism and feature summary.
R3 GLP from Wolf Research is a high-purity research-grade compound intended strictly for laboratory research use.
R3 GLP (Retatrutide (triple GIP/GLP-1/glucagon receptor agonist)) is supplied as a research-grade compound for in vitro study of incretin and metabolic receptor signaling pathways. GLP-class research compounds are widely used in laboratory studies of glucose metabolism, appetite-related pathways, and receptor pharmacology.
Every lot of R3 GLP is third-party tested for identity and purity, with certificates of analysis available on request. Supplied in sealed, sterile vials and shipped fast from our U.S. facility.
The products offered herein are intended exclusively for research purposes and must be utilized solely within in vitro environments (e.g., test tubes or laboratory settings) for the purposes of testing and experimentation. All information provided on this website is strictly for educational purposes and does not constitute legal or professional advice. It is imperative to acknowledge that the introduction of these products into humans or animals, in any capacity, is strictly prohibited by applicable laws and regulations. Violation of these regulations may result in legal repercussions. These products are intended solely for use by qualified, licensed professionals with the expertise to handle them safely and responsibly. Furthermore, it is important to note that these products are not classified as drugs, food, or cosmetics under any legal definitions. Any misbranding, misuse, or mislabeling of these products within these categories is expressly prohibited and may lead to further legal consequences. By adhering to these guidelines, you ensure compliance with all regulatory frameworks and contribute to the responsible conduct of scientific research.
Technical Data
| A novel synthetic peptide and triple hormone receptor agonist (GIP, GLP-1, and glucagon receptors) researched for its potent multi-pathway modulation of metabolic rate, glucose homeostasis, and lipid regulation. | |
|---|---|
| Key Benefits & Highlights | |
| Triple Receptor Agonism (GIP/GLP-1/GCG) | Simultaneously targets glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon (GCG) receptors, providing synergistic control over metabolic cascades. |
| Enhanced Energy Expenditure & Metabolic Rate | Glucagon receptor activation drives increased basal metabolic rate and lipolysis in research models, augmenting the primary glucose-lowering pathways. |
| Glycemic & Appetite Regulation | Researched for its ability to significantly enhance glucose-dependent insulin secretion, suppress excessive glucagon, and modulate central satiety signaling. |
| Lipid & Hepatic Fat Oxidation | Investigated in cellular for reducing intrahepatic fat accumulation and optimizing systemic lipid profiles. |
| High Chemical Purity | Synthesized and verified via analytical testing to ensure precise amino acid sequence fidelity and minimal experimental variance. |
| Standardized Research Reagent | Formulated for high reproducibility across in vitro receptor binding assays, metabolic pathway mapping, and obesity model protocols. |
| Feature Summary | |
| Product Class | Synthetic Tri-Agonist Peptide (GIP/GLP-1/Glucagon Receptor Agonist) |
| Primary Application | In vitro triple-receptor kinetics, metabolic regulation signaling research |
| Grade | Laboratory / Research Grade Only |